ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 117 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 2.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $454,000 | -11.7% | 14,750 | -15.7% | 0.15% | +98.6% |
| Q1 2016 | $514,000 | -90.6% | 17,487 | -85.6% | 0.07% | -86.1% |
| Q2 2015 | $5,448,000 | +723.0% | 121,085 | +460.2% | 0.53% | +718.5% |
| Q1 2015 | $662,000 | -39.8% | 21,615 | -0.0% | 0.06% | -38.1% |
| Q4 2014 | $1,099,000 | -70.4% | 21,618 | -76.9% | 0.10% | -67.3% |
| Q3 2014 | $3,711,000 | +703.2% | 93,771 | +364.9% | 0.32% | +1428.6% |
| Q3 2013 | $462,000 | +17.9% | 20,168 | -8.9% | 0.02% | +31.2% |
| Q2 2013 | $392,000 | – | 22,149 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |